[Psoriatic arthritis : Overview of drug therapy options and administration characteristics].

about

[Psoriatic arthritis : Overview of drug therapy options and administration characteristics].

Item

http://www.wikidata.org/entity/Q53760739

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

[Psoriatic arthritis : Overvie ...... ministration characteristics].

@en

type

Item

label

[Psoriatic arthritis : Overvie ...... ministration characteristics].

@en

prefLabel

[Psoriatic arthritis : Overvie ...... ministration characteristics].

@en

P1476

[Psoriatic arthritis : Overvie ...... ministration characteristics].

@en

P2093

D Thaçi

http://www.w3.org/2001/XMLSchema#string

F Behrens

http://www.w3.org/2001/XMLSchema#string

J Wollenhaupt

http://www.w3.org/2001/XMLSchema#string

K Krüger

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis

Does Concomitant Methotrexate with Adalimumab Influence Treatment Outcomes in Patients with Psoriatic Arthritis? Data from a Large Observational Study.

Leflunomide improves psoriasis in patients with psoriatic arthritis: an in-depth analysis of data from the TOPAS study.

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)

Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor.

Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT.

Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration.

Treatments for nail psoriasis: a systematic review by the GRAPPA Nail Psoriasis Work Group.

Dactylitis in psoriatic arthritis: a marker for disease severity?

A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis.

P2888

s00393-016-0110-6

P304

471-488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S00393-016-0110-6

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27259913

http://www.w3.org/2001/XMLSchema#string